Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Department of Error] Department of Error

Kirchhof P. The future of atrial fibrillation management: intergrated care and stratified therapy. Lancet 2017; 390: 1873–87—In table 4 of this Seminar (published online first on April 28), the dose of edoxaban should be 60 mg once daily. This correction has been made to the online version as of Oct 10, 2017, and the printed Seminar is correct.

email